DiscoverNEJM This Week
NEJM This Week
Claim Ownership

NEJM This Week

Author: NEJM Group

Subscribed: 16,172Played: 222,664
Share

Description

Concise summaries of everything published in the latest weekly issue of the New England Journal of Medicine (NEJM). NEJM publishes new medical research findings, review articles, and editorial opinion on topics of importance to biomedical science and clinical practice.
48 Episodes
Reverse
This week, we share advances in treatment for EGFR-mutated lung cancer, a brain-penetrant enzyme therapy for a rare pediatric disorder, and dual targeting of extramedullary myeloma. We review cardiogenic shock, work through a challenging diagnostic puzzle in a young woman with recurrent illness, and explore Perspectives on corporatized care, vaccine policy, AI in medicine, and where clinicians carry grief. Supplement to the New England Journal of Medicine, Vol. 394, No. 1.
We discuss the latest in medical research and ideas.
We discuss the latest in medical research and ideas.
We discuss the latest in medical research and ideas.
We discuss the latest in medical research and ideas.
We discuss the latest in medical research and ideas.
We discuss the latest in medical research and ideas.
We discuss the latest in medical research and ideas.
We discuss the latest in medical research and ideas.
We discuss the latest in medical research and ideas.
We discuss the latest in medical research and ideas.
We discuss the latest in medical research and ideas.
We discuss the latest in medical research and ideas.
We discuss the latest in medical research and ideas.
We discuss the latest in medical research and ideas.
We discuss the latest in medical research and ideas.
We discuss the latest in medical research and ideas.
We discuss the latest in medical research and ideas.
We discuss the latest in medical research and ideas.
We discuss the latest in medical research and ideas.
loading
Comments (2)

ali_mostafa_zadeh

is there any transcript for this podcast?

Sep 26th
Reply

Iman

That's excellent, I hope to continue!

Jul 16th
Reply